Ingevity Corporation (NYSE: NGVT) today announced that it has invested $60 million to acquire an equity stake in Nexeon Limited ("Nexeon") in a strategic move to establish the company's presence in the electric vehicle (EV) market and expand opportunities to grow its activated carbon business.
Ingevity (NYSE:NGVT) is set to give its latest quarterly earnings report on Tuesday, 2022-08-02. Here's what investors need to know before the announcement.
Analysts estimate that Ingevity will report an earnings per share (EPS) of $1.62.
Ingevity (NYSE:NGVT) reported its Q1 earnings results on Wednesday, May 4, 2022 at 05:15 PM.
Here's what investors need to know about the announcement.
Earnings
Ingevity beat estimated earnings by 55.77%, reporting an EPS of $1.62 versus an estimate of $1.04.
Ingevity (NYSE:NGVT) reported quarterly earnings of $1.62 per share which beat the analyst consensus estimate of $1.04 by 55.77 percent. This is a 27.56 percent increase over earnings of $1.27 per share from the same
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.